NAV as of Sep 25, 2024
$76.68
52 WK: 64.60 - 79.07
1 Day NAV Change as of Sep 25, 2024
-0.58
(-0.75%)
NAV Total Return as of Sep 25, 2024
YTD:
13.27%
Morningstar Rating
5 stars
BRONZE
Overview
About this Fund
1. Access to innovative healthcare equities 2. Investment expertise enhanced by scientific experience 3. Seeks diversified returns with lower volatility
Investment Approach
Invests at least 80% of total assets in securities of companies in health sciences and related industries, and may invest in companies located in non-U.S. countries.